Drooling (Sialorrhea)

Overview

Category: Non-motor symptom (Autonomic)

Prevalence: Up to 70%

Detailed Information

Sialorrhea in PD is primarily due to decreased frequency of spontaneous swallowing rather than excess saliva production. In fact, salivary flow rates are often normal or reduced in PD. The problem lies in the accumulation of saliva in the mouth due to infrequent, inefficient swallowing combined with poor lip seal and reduced oral motor control. Drooling worsens during activities that demand attentional resources (reading, watching television, conversation), as the automatic swallowing reflex competes for the same cognitive resources that are impaired in PD.

Drooling can cause embarrassment, social withdrawal, perioral skin irritation and maceration, and increased aspiration risk. It is one of the most socially stigmatizing PD symptoms and is rated by patients as one of the most bothersome non-motor features. Nighttime drooling is common and can cause wet pillows, disrupted sleep, and aspiration risk.

Pathophysiology: Why This Happens

The normal adult swallows approximately 600 times per day, with the majority of swallows being unconscious, automatic acts. In PD, the basal ganglia dysfunction that impairs other automatic motor programs also reduces the frequency and efficiency of spontaneous swallowing. Studies show that PD patients swallow approximately half as often as age-matched controls during rest.

The oral phase of saliva management is also affected: reduced lip seal strength (from orofacial bradykinesia), poor bolus formation, and inefficient tongue movements allow saliva to pool in the anterior oral cavity and overflow. Head flexion, which is common due to axial rigidity and the characteristic stooped posture of PD, tilts the oral cavity forward, making anterior drooling more likely.

Salivary gland function is modulated by both sympathetic and parasympathetic innervation. While overall salivary production may be mildly reduced in PD (some patients develop dry mouth), the relative excess is one of flow versus clearance -- saliva is produced at a normal rate but cleared at a dramatically reduced rate.

Prevalence and Demographics

Sialorrhea affects approximately 56-78% of PD patients across studies. It is more common and severe in patients with greater motor impairment, longer disease duration, more prominent axial symptoms, and concurrent dysphagia and speech changes. Men with PD may be slightly more affected than women.

Drooling severity correlates with overall disease severity and is more common in the PIGD subtype. It typically becomes clinically significant in the middle stages of disease (stages 2-3) and often worsens progressively. Among PD patients with sialorrhea, approximately 30% rate it as moderate-to-severe, interfering significantly with daily activities.

Differential Diagnosis

Several other conditions can cause similar symptoms. A thorough medical evaluation is essential to distinguish Parkinson's-related drooling (sialorrhea) from other causes:

True sialorrhea (overproduction of saliva) should be distinguished from the pseudo-sialorrhea of PD, where the problem is impaired clearance. Measuring salivary flow rates can help differentiate, though this is rarely necessary in clinical practice. Medications that increase salivation (clozapine, cholinesterase inhibitors, pilocarpine) should be identified.

Oral conditions including dental infections, mouth ulcers, and poorly fitting dentures can increase salivation or worsen drooling. Gastroesophageal reflux can stimulate salivary reflexes. In younger patients, drooling may suggest bulbar-onset motor neuron disease (ALS), which should be considered if rapid progression or upper motor neuron signs are present.

How This Symptom Changes by Stage

In stages 1-2, drooling is usually absent or very mild. Some patients may notice a slightly wet pillow upon waking or occasional excess saliva when concentrating on other tasks.

At stage 3, drooling becomes noticeable and may cause social embarrassment. Patients begin to keep tissues handy or avoid social situations where drooling would be visible. Speech clarity may be affected by excess saliva in the oral cavity.

In stages 4-5, drooling can be severe and constant, requiring frequent wiping, chin bibs, or absorbent clothing. The combination of severe drooling with dysphagia increases aspiration risk substantially. Perioral skin breakdown may occur from chronic moisture exposure.

Stage-by-Stage Quick Reference

A summary of how drooling (sialorrhea) typically presents at each Hoehn & Yahr stage:

Stage 2

May begin to appear

Stage 3

Often noticeable

Stage 4

Frequently problematic

Stage 5

Severe and constant

Management Strategies

Behavioral strategies focus on increasing conscious swallowing frequency. Patients can set reminders to swallow at regular intervals, consciously swallow before speaking, and maintain an upright head position. Chewing sugar-free gum or sucking on hard candy can stimulate the swallowing reflex.

Pharmacological interventions include glycopyrrolate (an anticholinergic that reduces salivary secretion and has limited blood-brain barrier penetration, thus fewer cognitive side effects than systemic anticholinergics), sublingual atropine drops (1% ophthalmic solution placed under the tongue), and ipratropium bromide spray (an anticholinergic bronchodilator used off-label in the oral cavity).

Botulinum toxin injection into the parotid and/or submandibular glands is the most effective treatment for moderate-to-severe sialorrhea, with Level A evidence from randomized controlled trials. Injections typically provide 3-4 months of benefit and can be repeated. Both onabotulinumtoxinA (Botox) and rimabotulinumtoxinB (Myobloc) are used, with incobotulinumtoxinA (Xeomin) having specific FDA approval for sialorrhea.

Radiotherapy to the salivary glands is an option for refractory cases but is rarely needed. Surgical options (salivary duct ligation, gland excision) are available but uncommonly performed given the effectiveness of botulinum toxin.

Practical Tips

• Consciously swallow more frequently
• Keep head in upright position
• Chew sugar-free gum to stimulate swallowing
• Discuss glycopyrrolate or atropine drops with doctor
• Botulinum toxin injections for salivary glands may help

When to See a Doctor

If drooling causes skin irritation, social embarrassment, or if you notice frequent coughing or choking from saliva.

The Bigger Picture

Drooling exemplifies the social stigma dimension of PD that goes beyond physical disability. Patients frequently describe drooling as the symptom they find most embarrassing and most damaging to their self-image and social confidence. The visible nature of drooling triggers assumptions about cognitive impairment that may be entirely unwarranted.

The good news is that effective treatments exist. Botulinum toxin injection into the salivary glands is safe, well-studied, and provides meaningful relief for the majority of treated patients. Patients suffering from drooling should be informed that this is a treatable symptom and encouraged to raise it with their neurologist rather than suffering in silence.